PL324340A1 - Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acids - Google Patents

Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acids

Info

Publication number
PL324340A1
PL324340A1 PL96324340A PL32434096A PL324340A1 PL 324340 A1 PL324340 A1 PL 324340A1 PL 96324340 A PL96324340 A PL 96324340A PL 32434096 A PL32434096 A PL 32434096A PL 324340 A1 PL324340 A1 PL 324340A1
Authority
PL
Poland
Prior art keywords
quinoxalinophosphonic
quinoxalinoalkanophosphonic
acids
novel
quinoxalinoalkanophosphonic acids
Prior art date
Application number
PL96324340A
Other languages
English (en)
Inventor
Robert Moretti
Hans Allgeier
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PL324340A1 publication Critical patent/PL324340A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/650952Six-membered rings having the nitrogen atoms in the positions 1 and 4
    • C07F9/650994Six-membered rings having the nitrogen atoms in the positions 1 and 4 condensed with carbocyclic rings or carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40Benzopyrazines
    • C07D241/44Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL96324340A 1995-07-10 1996-07-01 Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acids PL324340A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH200995 1995-07-10

Publications (1)

Publication Number Publication Date
PL324340A1 true PL324340A1 (en) 1998-05-25

Family

ID=4223780

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96324340A PL324340A1 (en) 1995-07-10 1996-07-01 Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acids

Country Status (15)

Country Link
EP (1) EP0837864A1 (no)
JP (1) JPH11508902A (no)
KR (1) KR19990028839A (no)
AU (1) AU6516296A (no)
BR (1) BR9609644A (no)
CA (1) CA2224718A1 (no)
CZ (1) CZ5398A3 (no)
HU (1) HUP9901345A3 (no)
IL (1) IL122872A0 (no)
NO (1) NO980095L (no)
PL (1) PL324340A1 (no)
SK (1) SK2798A3 (no)
TR (1) TR199800022T1 (no)
WO (1) WO1997003079A1 (no)
ZA (1) ZA965800B (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3908790B2 (ja) * 1996-10-24 2007-04-25 ノバルティス アクチエンゲゼルシャフト 置換アミノアルカンホスホン酸
US6841684B2 (en) 1997-12-04 2005-01-11 Allergan, Inc. Imidiazoles having reduced side effects
US6329369B1 (en) 1997-12-04 2001-12-11 Allergan Sales, Inc. Methods of treating pain and other conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118675A (en) * 1991-02-15 1992-06-02 American Home Products Corporation Quinoxaline phosphono-amino acids
IL109397A0 (en) * 1993-04-28 1994-07-31 Schering Ag Quinoxalinedione derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
JPH11508902A (ja) 1999-08-03
EP0837864A1 (en) 1998-04-29
KR19990028839A (ko) 1999-04-15
ZA965800B (en) 1997-01-10
TR199800022T1 (xx) 1998-05-21
SK2798A3 (en) 1998-07-08
HUP9901345A3 (en) 2000-01-28
IL122872A0 (en) 1998-08-16
CZ5398A3 (cs) 1998-06-17
HUP9901345A2 (hu) 1999-08-30
WO1997003079A1 (en) 1997-01-30
CA2224718A1 (en) 1997-01-30
AU6516296A (en) 1997-02-10
BR9609644A (pt) 1999-05-11
NO980095D0 (no) 1998-01-09
NO980095L (no) 1998-03-05
MX9800332A (es) 1998-07-31

Similar Documents

Publication Publication Date Title
IL122428A0 (en) Minizymes and minribozymes and uses thereof
HK1002864A1 (en) Water-dissoluble narobomycin ester
PL338357A1 (en) Some 5-alkyl-2-arylaminophenyloacetic acids and their derivatives
EP0708482A3 (en) BiCDMOS manufacturing technology and its structures
IL122392A0 (en) Structurally determined metallo-constructs and applications
AU6490396A (en) Substituted-pent-4-ynoic acids
EP0851759A4 (en) COMPOUNDS AND RELATED METHODS
IL113384A0 (en) Alpha-aminolakanoic acids and reduction products
GB9325558D0 (en) Percaboxylic acids
ZA962768B (en) Benzonitriles and benzofluorides
EP0801644A4 (en) POLYARYLCARBAMOYLAZADIOQUE ACIDS AND CARBAMOYLALCANEDIO QUES
HU9500728D0 (en) 5-vinyl- and 5-ethinyl-quinolon- and -naphtiridone-carboxylig acids
GB9510830D0 (en) Proteins
PL332553A1 (en) 3-alkooxyisooxazol-4-yl-substituted 2-aminocarboxylic acids
EP0836617A4 (en) PAREVINES AND TACHYTEGRINES
GB9516309D0 (en) Novel compounds and process
ZA968451B (en) Novel sulfonylaminopyrimidines
ZA964862B (en) Optimized minizymes and miniribozymes and uses thereof
SI1043332T1 (sl) Dipeptidi, ki obsegajo ciklopentan-beta-aminokisline
HUP9801330A3 (en) Novel pka-binding proteins and uses thereof
EP0744125A3 (en) Iodine complex and its application
GB9423372D0 (en) Proteins and their uses
AU5188296A (en) Carbopeptoids and carbonucleotoids
PL324340A1 (en) Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acids
IL120903A0 (en) Fluoroalkylglycosiduronic acids and corresponding 6(3)-lactones their preparation and their uses